MannKind develops dry powder inhaler for pulmonary hypertension treatment
Go back to MannKind develops dry powder inhaler for pulmonary hypertension treatment| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 3.29 -0.13 (3.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.42 | 52 Week High | $2.51 | |||
| Open | $3.40 | 52 Week Low | $0.41 | |||
| Day High | $3.41 | P/E | N/A | |||
| Day Low | $3.23 | EPS | $-0.64 | |||
| Volume | 4,549,652 | |||||
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 549.16 +16.38 (3.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $532.78 | 52 Week High | $164.04 | |||
| Open | $528.92 | 52 Week Low | $97.52 | |||
| Day High | $551.15 | P/E | 100.39 | |||
| Day Low | $528.92 | EPS | $5.47 | |||
| Volume | 577,863 | |||||



